Last updated: 2026-09-17 13:24:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
AETHLON MEDICAL INC. (AEMD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $8.98, with a market capitalization of $1.05M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.31 to $41.35. This page covers its latest market performance, valuation, price trends and company information.
$1.05M | |
$1.40 | |
$735,000.00 | |
$1.31 | |
$1.43 | |
46.56M | |
1.06M | |
-- | |
$41.35 | |
$1.31 | |
-- | |
-- |
AETHLON MEDICAL INC. (AEMD) is trading at $8.98 in pre-market trading as of 2026-09-17 13:08:53, up 528.04% ($7.55) from the previous close of $1.43
Pre-market trading shows how investors are pricing AEMD before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, AETHLON MEDICAL INC. (AEMD) moved from $1.81 to $8.98, representing a gain of 396.35% ($7.17).
The stock traded between $1.31 and $9.67 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 79.19 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 19.2%
AEMD is currently trading at $8.98, placing it 19.2% of the way from its 52-week low of $1.31 to its 52-week high of $41.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 9 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of AETHLON MEDICAL INC. (AEMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.